Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetic patients with multi-vessel coronary disease: A meta-analysis

Diabetes Research and Clinical Practice

Volumn 97, Issue 2, 2012, Pages 178-184

  Zhang, Fan ^a   Yang, Yuan ^a   Hu, Dayi ^a   Lei, Han ^a   Wang, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

CABG; Diabetes mellitus; Meta analysis; PCI

Indexed keywords

INSULIN;

ADULT; AGED; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DIABETIC PATIENT; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; MULTI VESSEL CORONARY DISEASE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84865080708     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.03.020     Document Type: Review

References (31)

1. Yang W., Lu J., Weng J., Ji L., Xiao J., Shan Z., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
2. Sarah W., Richard S., Gojka R., Sicree R., King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
3. Kereiakes D.J., Cutlip D.E., Applegate R.J., Wang J., Yaqub M., Sood P., et al. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). J Am Coll Cardiol 2010, 14(56(25)):2084-2089.
4. Haffner S.M., Lehto S., Ronnemaa T., Pyörälä K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
5. Smith S.C., Faxon D., Cascio W., Schaff H., Gardner T., Jacobs A., et al. Diabetes and cardiovascular disease writing group VI: revascularization in diabetic patients. Circulation 2002, 105:e165-e169.
6. Carson J.L., Scholz P.M., Chen A.Y., Peterson E.D., Gold J., Schneider S.H. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002, 40:418-423.
7. Review Manager (RevMan). Cochrane handbook for systematic reviews of interventions 4.2.6. The Cochrane Collaboration; 2006.
8. Jaime L.P., Alex J.S., David R.J., Avin K.G., Bialocerkowski A.E., Crossley K.M. Assessing publication bias in meta-analyses in the presence of between-study heterogeneity. J Royal Stat Soc 2010, 173(3):575-591.
9. Serruys P.W., Andrew T.L., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol 2005, 46(4):575-581.
10. Abizaid A., Marco A.C., Centemero M., Abizaid A.S., Legrand V.M., Limet R.V., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients insights from the arterial revascularization therapy study (ARTS) trial. Circulation 2001, 104:533-538.
11. Legrand V.M.G., Serruys P.W., Unger F., van Hout B.A., Vrolix M.C., Fransen G.M., et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 2004, 109:1114-1120.
12. Unger F., Patrick W.S., Magdi H.Y., Ilsley C., Paulsen P.K., Nielsen T.T., et al. Revascularization in multivessel disease: comparison between two-year outcomes of coronary bypass surgery and stenting. J Thorac Cardiovasc Surg 2003, 125:809-820.
13. Sedlis S.P., Morrison D.A., Lorin J.D., Esposito R., Sethi G., Sacks J., et al. Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 2002, 40(9):1555-1566.
14. The BARI Investigators Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000, 35(5):1122-1129.
15. The BARI Investigators The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 2007, 49(15):1600-1606.
16. Detre K.M., Guo P., Holubkov R., Califf R.M., Sopko G., Bach R., et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the bypass angioplasty revascularization investigation (BARI). Circulation 1999, 99:633-640.
17. Adrian P.B., Stephen W.M., Marie C.M., Kappetein A.P., Mohr F.W., Berti S., et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010, 55(11):1067-1075.
18. Akhil K., Roger J.H., Iqbal S.M., Qureshi A.C., Butts J., de Belder M., et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients 1-year: results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010, 55(5):432-440.
19. Rodriguez A.E., Baldi J., Pereira C.F., Navia J., Rodriguez Alemparte M., Delacasa A., et al. Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005, 46(4):582-588.
20. King S.B., Kosinski A.S., Guyton R.A., Lembo N.J., Weintraub W.S. Eight-year mortality in the Emory angioplasty versus surgery trial (EAST). J Am Coll Cardiol 2000, 35(5):1116-1121.
21. Paulo R.S., Whady A.H., Pedro A.L., Lopes N., Martinez E.E., Cesar L.A., et al. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the medicine, angioplasty, or surgery study (MASS II). Circulation 2006, 114(Suppl. I):I-420-I-424.
22. Booth J., Clayton T., Pepper J., Nugara F., Flather M., Sigwart U., et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease six-year follow-up from the stent or surgery trial (SoS). Circulation 2008, 118:381-388.
23. Brener S.J., Lytle B.W., Casserly I.P., Ellis S.G., Topol E.J., Lauer M.S. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur Heart J 2006, 27:413-418.
24. Arvinder S.K., Timothy J.B., Charles D.I., Sigwart U., Rickards A.F. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol 2001, 87:947-950. CABRI Investigators (Coronary Angioplasty versus Bypass Revascularization Investigation).
25. Joost D., Karl H.K., Carlos M., LeGrand V., Vrolix M., Carrie D., et al. Multivessel coronary revascularization in patients with and without diabetes mellitus 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study - part II) trial. J Am Coll Cardiol 2008, 52:1957-1967.
26. Dena M.B., Allison L.G., Kathryn M.M., Sundaram V., Perez M.V., Varghese R., et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007, 147:703-716.
27. Holper E.M., Abbott J.D., Mulukutla S., Vlachos H., Selzer F., McGuire D., et al. Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry. Am Heart J 2011, 161(2):397-4030.
28. Bernard R.C., Regina M.H., Dale A., Gebhart S., Grogan M., Ocampo S., et al. The bypass angioplasty revascularization investigation 2 diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009, 120:2529-2540.
29. Kansagara D., Fu R., Freeman M., Wolf F., Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011, 154(4):268-282.
30. Wright R.S., Anderson J.L., Adams C.D., Bridges C.R., Casey D.E., Ettinger S.M., et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 57(19):e215-e367.
31. Rao S.V., Cohen M.G., Kandzari D.E., Bertrand O.F., Gilchrist I.C. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol 2010, 55(20):2187-2195.